LU2300295123
LU2300295123
Amundi Prime Emerging Markets UCITS ETF DR (C)
Loading chart...
About this ETF
The Amundi Prime Emerging Markets UCITS ETF DR (C) seeks to track the Solactive GBS Emerging Markets Large & Mid Cap index. The Solactive GBS Emerging Markets Large & Mid Cap index tracks large and mid-cap stocks from emerging markets worldwide.
TER
0.1%
Total Expense Ratio per year
Fund Size
€1.7B
Assets under management
Holdings
1,930
Underlying equities
Dividend Yield
0%
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
14.99
Weighted Fwd P/E
9.7
💰 Revenue Estimates
Current Year CY
+42.74% ⌀ 21 Analysts Coverage
Next Year NY
+22.3% ⌀ 24 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
+287.21% ⌀ 20 Analysts Coverage
Next Year NY
+44.62% ⌀ 20 Analysts Coverage
Related ETFs
Vanguard Emerging Markets Stock Index Fund USD Acc
363.77 USD
TER 0.23% 1Y +26.1%
Vanguard Emerging Markets Stock Index Fund EUR Acc
324.9 EUR
TER 0.23% 1Y +30.7%
Vanguard Emerging Markets Stock Index Fund GBP Acc
423.35 GBP
TER 0.23% 1Y +27.9%
Vanguard Emerging Markets Stock Index Fund GBP Dist
295.95 GBP
TER 0.23% 1Y +25.3%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
09/14/2021 (5 yrs)
Index Group
Solactive GBS Emerging Markets Large & Mid Cap Region
Emerging Markets Country
-
Sector
-
Strategy
-
Theme
-
Distribution Policy
Accumulating Replication
Full replication Sustainable
No 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
5/7 Elevated
Diversification Score: 67/100 Moderate
Diversification Score
67/100 Moderate
5Y Volatility
18.8% p.a.
Max Drawdown (5Y)
-31.2%
Sharpe Ratio (5Y)
0.32
Beta Factor
1.00
Notes & Warnings
Fund Volume (AUM) 🟢 Established large fund (> 500M € AUM)
🟡 Moderate analyst coverage (19.7 analysts)
⚠️ Elevated emerging markets risk: 100% Emerging Markets.
⚠️ Sector concentration: 40% in "Technology".
ℹ️ Tech-Capex Exposure: 41% in semiconductors & hardware – dependent on hyperscaler capex cycles.
⚠️ Elevated Regulatory & Policy Risk: 39% in heavily regulated industries (defense, regulated utilities, healthcare policy).